Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

23 results about "Organism" patented technology

In biology, an organism (from Greek: ὀργανισμός, organismos) is any individual entity that propagates the properties of life. It is a synonym for "life form". Organisms are classified by taxonomy into specified groups such as the multicellular animals, plants, and fungi; or unicellular microorganisms such as a protists, bacteria, and archaea. All types of organisms are capable of reproduction, growth and development, maintenance, and some degree of response to stimuli. Humans are multicellular animals composed of many trillions of cells which differentiate during development into specialized tissues and organs.

Soil improvement method for planting blueberries

InactiveCN103609219AMaintain fertilityLower pHSoil lifting machinesFertilising methodsPeatOrganism
The invention relates to a soil improvement method, in particular to a soil improvement method for planting blueberries. The method mainly solves the technical problems that existing blueberry planting soil improvement measurements affect soil organism conditions, are high in cost and have toxic action on blueberry roots. The method includes the steps that firstly, fermented furfural residues are evenly applied to soil to be improved in summer, and turning plough is performed to make the fermented furfural residues and the soil fully mixed; secondly, after 1-1.5 months, peat, saw dust and organic fertilizer are applied to the soil, and turning plough is performed to make the peat, the saw dust and the organic fertilizer fully mixed with the soil; thirdly, manual weeding is performed; fourthly, soil plowing and ridging are performed in the spring of the next year, and the improvement to the soil for planting blueberries is completed. The pH value of the improved soil is 4.5-4.8, nutrient status of the soil is improved, and the survival rate of transplanted biennial blueberries and the survival rate of six-year-growing-period blueberries can reach 95-96% and 96-97% respectively. The method is used for blueberry cultivation.
Owner:JILIN NORMAL UNIV

Methods of regulating differentiation in mammals

Mechanisms regulating cell proliferation stop and differentiation initiation during the development stage of mammalian embryo, and the proteins involved therein, are presented. Differentiation regulators, methods of regulating differentiation, transgenic organisms with loss of expression of the differentiation regulator, and methods of preparing the transgenic organisms, are provided.
Owner:KOREA ADVANCED INST OF SCI & TECH

Altered DNA synthesome components as biomarkers for malignancy

InactiveUS20060073477A1Guaranteed functionChange activityPeptide/protein ingredientsMicrobiological testing/measurementMalignant phenotypeNeoplasm
Antibodies which specifically bind to components of the DNA synthesome which are altered in malignant cells are disclosed. These antibodies can be used, inter alia, to diagnose, prognoses, and treat malignancy and in assays to screen cells, tissues, and body fluids for the presence of a malignant phenotype. These antibodies can be further used to identify test compounds having the ability to suppress the malignant phenotype in a cell by assaying for the ability to inhibit or block the function of an altered component of the DNA synthesome associated with the malignant phenotype. Further, disclosed herein are methods and kit for minimally invasively detecting the presence of neoplasms and malignant conditions using easily obtainable body fluids, such as blood, plasma, lymph, pleural fluid, spinal fluid, saliva, sputum, urine, and semen, for example, to both detect the presence of cancer as well as assess the stage of the disease and the prognosis of the patient. By detecting the presence of an altered form of a component of the DNA synthesome in body fluid, one can diagnose and prognose malignancy. The disclosed method and kit therefor can be used as a diagnostic biomarker for malignancy as well as a means of monitoring the progress and effectiveness of therapeutics.
Owner:SCHNAPER LAUREN

Recombinant adenovirus rAd-ORF2-TCE and application thereof

InactiveCN103805573AEnhance humoral immunityEnhance cellular immunityGenetic material ingredientsMicroorganism based processesPorcine circovirusOrganism
The invention relates to a recombinant adenovirus rAd-ORF2-TCE. The recombinant adenovirus rAd-ORF2-TCE is obtained through fusing and connecting an immunogenic protein gene ORF2 of PCV2 (Porcine Circovirus Type 2) and three T lymphocyte epitope (TCE) series genes, and then, recombining to an adenovirus vector. The invention further relates to application of the recombinant adenovirus rAd-ORF2-TCE in porcine viral immunization vaccines. According to the recombinant adenovirus rAd-ORF2-TCE disclosed by the invention, an organism can be effectively stimulated to generate a high-level specific antibody and generate T lymphocyte proliferation, and both the concentration of IFN-gamma in blood serum and the concentration of IL-2 in the blood serum are increased remarkably; compared with ORF2 of separate PCV2, the recombinant adenovirus rAd-ORF2-TCE has the advantage that both humoral immunity level and cellular immunity level of an animal body are increased remarkably.
Owner:GUANGDONG WENS DAHUANONG BIOTECH +1

Method for facilitating in-vitro maturation of human immature oocytes by utilizing 3D printing technology

InactiveCN106566800AIn vitro maturationLow technical costGerm cellsHuman bodyMaturation oocyte
The invention relates to the technical field of biological 3D printing, in particular to a method for facilitating in-vitro maturation of human immature oocytes by utilizing a 3D printing technology. The method comprises the following steps of (1) properly treating naked ova and granular cells of ovary cells; (2) performing in-vitro balanced culture of ovarian granular cells; (3) putting oocytes into the ovarian granular cells, and continuing to perform culture for 2 days; (4) preparing 3D printing ink; (5) preparing 3D printing gel; and (6) printing out follicles by adopting the 3D printing technology, putting the oocytes and an in-vitro maturation culture solution into the follicles, and performing culture for one week. According to the method, the follicles with a biochemical environment similar to that of a human body try to be simulated, and then the oocytes are quickly and accurately put into the follicles for performing artificial culture by depending on the 3D printing technology, so that the in-vitro maturation of the human immature oocytes is realized; the method depends on the 3D printing technology; and the whole process is quick and convenient, and the automation degree is high, so that the technical expense of the in-vitro maturation of the oocytes can be reduced.
Owner:GUANGXI MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products